Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Usage of Omics Technology for Identification of Critical Mediators and Pathways in Patients with Hidradenitis Suppurativa
2016-001566-28Phase 4Terminated
- Sponsor
- University College Dublin
- Start
- Jun 2016
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of adalimumab in hidradenitis suppurativa (HS), sponsored by University College Dublin. Primary endpoint: Primary endpoint: inflammatory profiles in skin biopsies and microdialysate. Started Jun 2016; status: terminated.
02
Drugs
03
Conditions
hidradenitis suppurativa (HS)
Beyond the preview
Go deeper on 2016-001566-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001566-28.